News
For leaders in business, failing to learn the lessons of a crisis can be disastrous. For leaders in government, when millions ...
6h
The Dispatch on MSNThe Risks of Trump’s Turn Against mRNA Vaccines
The mRNA platform enabled scientists to begin work on a vaccine within days of the publication of COVID-19’s genetic sequence. Clinical trials for an mRNA vaccine began weeks la ...
"I am saddened and outraged that more citizens are not tuning into this war against scientific health research in the United ...
The ability to correct disease-causing genetic mistakes using genome editors holds great promise in medicine, but it is not ...
The deal gives Gilead ownership of a technology that can genetically modify immune cells inside the body, an approach could potentially widen access to CAR-T treatment.
Senior author Elias Sayour, M.D., Ph.D., a UF Health pediatric oncologist, said the results reveal a potential new treatment path — an alternative to surgery, radiation, and chemotherapy — with broad ...
The quest for a vaccine against HIV has been going on for about 40 years — almost as long as the virus that causes AIDS has ...
The ability to correct disease-causing genetic mistakes using genome editors holds great promise in medicine, but it is not without risk. When this type of “genetic surgery” is performed on DNA, for ...
Researchers warn that halting federal contracts for mRNA vaccine research could weaken pandemic preparedness and slow medical advances.
Dubbed the ‘guardian of the genome’, the p53 protein responds to DNA damage by stalling cell division, initiating DNA repair or triggering cell death. This well-known pathway is frequently mutated or ...
The cuts risk making the world a more dangerous place. To assess the impact of these measures, The Economist spoke to more ...
In 1957, just four years after Francis Crick and other scientists solved the riddle of DNA’s structure—the now famous double ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results